Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Autoimmune inflammatory myopathy after treatment with ipilimumab.

× No keyword cloud information.

33 in total

Review 1. Immunomodulatory therapy for melanoma: ipilimumab and beyond.

Authors: Margaret K Callahan; Michael A Postow; Jedd D Wolchok
Journal: Clin Dermatol Date: 2013 Mar-Apr Impact factor: 3.541

Review 2. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

Authors: Melinda Liu; Yuan Yu M Huang; Sylvia Hsu; Joseph S Kass
Journal: CNS Drugs Date: 2016-12 Impact factor: 5.749

Review 3. Incidence and Management of Immune-Related Adverse Events in Patients Undergoing Treatment with Immune Checkpoint Inhibitors.

Authors: Lisa A Kottschade
Journal: Curr Oncol Rep Date: 2018-03-06 Impact factor: 5.075

Review 4. Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.

Authors: Hiroki Nagai; Manabu Muto
Journal: Int J Clin Oncol Date: 2018-03-07 Impact factor: 3.402

Review 5. Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors: Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal: Curr Neurol Neurosci Rep Date: 2017-08-17 Impact factor: 5.081

6. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma.

Authors: Bing Liao; Sheetal Shroff; Carlos Kamiya-Matsuoka; Sudhakar Tummala
Journal: Neuro Oncol Date: 2014-01-30 Impact factor: 12.300

Review 7. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.

Authors: Hiroko Kadota; Takahisa Gono; Yuichiro Shirai; Yuka Okazaki; Mitsuhiro Takeno; Masataka Kuwana
Journal: Curr Rheumatol Rep Date: 2019-02-21 Impact factor: 4.592

Review 8. Autoimmune myositis and myasthenia gravis resulting from a combination therapy with nivolumab and ipilimumab for metastatic melanoma.

Authors: Ravi Sutaria; Parit Patel; Abhijeet Danve
Journal: Eur J Rheumatol Date: 2019-04-09

9. A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles after Combination Therapy with Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer.

Authors: William Carrera; Brandon J Baartman; Gregory Kosmorsky
Journal: Neuroophthalmology Date: 2017-03-15

Review 10. Ipilimumab and its toxicities: a multidisciplinary approach.

Authors: Leslie A Fecher; Sanjiv S Agarwala; F Stephen Hodi; Jeffrey S Weber
Journal: Oncologist Date: 2013-06-17